Featured Research
View our Cancer and Blood Diseases Institute featured research from the divisions of Bone Marrow Transplantation and Immune Deficiency, Experimental Hematology and Cancer Biology, Hematology and Oncology.
- Bone Marrow Transplantation and Immune Deficiency
Eculizumab Improves Survival When Stem Cell Transplant Patients Develop High-Risk TA-TMA - Experimental Hematology and Cancer Biology
Blood Stem Cells Use Mitochondria to Limit Self-Renewal Activity - Hematology
Dose Escalation Sharply Improves Hydroxyurea Benefit for Children with Sickle Cell Anemia - Oncology
Clinical Trial Success Leads to FDA Approval for Selumetinib for Children with Inoperable Plexiform Neurofibromas
